Repeated screening for colorectal cancer with fecal occult
blood test in Catalonia, Spain
Montse Garcia
a,b
, Josep Maria Borra `s
a,c,e
, Gemma Binefa
a,b
, Nu ´ ria Mila `
a,b
,
Josep Alfons Espina `s
a,c,e
and Vı ´ctor Moreno
b,c,d
The objective of this study was to explore the variables
associated with repeated screening for colorectal cancer
(CRC) among individuals aged 50–69 years in Catalonia,
Spain. We selected for the study all individuals (n = 11 969)
screened by a population-based CRC screening program in
2004 and who were eligible for rescreening in two years. A
multilevel logistic regression model was derived. The
contextual variables were the percentage of people with
less than primary studies and the percentage of CRC
screening participation. The individual variables used were:
sex, age, CRC screening (prior to 2004), guaiac fecal occult
blood test result, ease of recruitment, and number of tests
used. The rescreening rate was 87%. No differences
according to sex and age were found. The strongest barrier
for CRC rescreening was an inconclusive fecal occult blood
test result at baseline screening [odds ratio (OR): 0.24;
95% confidence intervals (CI): 0.20–0.29]. Individuals who
agreed to participate just after receiving the screening
invitation were more likely to accept a second screen
compared with those who received a reminder letter six
weeks later (OR: 1.53; 95% CI: 1.36–1.73). Those
individuals who lived in a neighborhood with a higher
educational level were more willing to rescreen
(OR: 1.22; 95% CI: 1.03–1.45) than those who lived in
more deprived areas. Rescreening was highly
adequate in our program, reflecting satisfaction with the
service received at screening. Strategies to enhance initial
screening participation for CRC and to improve quality
throughout the screening process should be
prioritized. European Journal of Cancer Prevention 21:42–
45 c 2011 Wolters Kluwer Health | Lippincott Williams &
Wilkins.
European Journal of Cancer Prevention 2012, 21:42–45
Keywords: colorectal cancer, mass screening, participation, rescreening
a
Cancer Prevention and Control Group, IDIBELL,
b
Catalan Institute of Oncology-
ICO, L’Hospitalet de Llobregat,
c
Department of Clinical Sciences, University of
Barcelona,
d
Colorectal Cancer Group, IDIBELL, L’Hospitalet de Llobregat and
e
Catalan Cancer Plan, Catalan Health Government, Barcelona, Spain
Correspondence to Montse Garcia, PhD, Cancer Prevention and Control Unit,
Catalan Institute of Oncology, Av. Gran Via 199-203, L’Hospitalet de Llobregat.
Barcelona 08908, Spain
Tel: +34 93 260 71 86; fax: +34 93 260 79 56;
e-mail: mgarcia@iconcologia.net
Received 13 April 2011 Accepted 12 June 2011
Introduction
Early detection can play an important role in reducing
colorectal cancer (CRC) mortality (Gouveia et al., 2008).
High level of ongoing and timely participation in screen-
ing is necessary to determine its effectiveness in reducing
mortality from CRC (Calazel-Benque et al., 2011).
However, most studies have focused on one-time screen-
ing rather than repeat adherence. Thus, little is known
about the determinants of adherence to repeat fecal
testing in population-based CRC screening programs.
The objective of this study was to explore the variables
associated with rescreening for CRC among men and
women aged 50–69 years in Catalonia, Spain.
Methods
Study population
The study population (n = 11 969) included men and
women aged 50–69 years who had been screened by the
Catalan CRC screening pilot program in 2004 and who
remained eligible to repeat screening two years later
(Fig. 1). A person was considered screened (participant)
when a completed fecal occult blood test (FOBT) kit was
returned, irrespective of the results.
Screening procedure
A detailed description of the screening procedure is
provided elsewhere (Peris et al., 2007). In brief, a biennial
screening program for CRC using FOBT was implemen-
ted in the Hospitalet de Llobregat, an industrial city of
239 000 inhabitants in 2000. Participants collected two
stool samples from each of three consecutive bowel
movements. The possible results of the FOBT were:
(a) weakly positive: one to four positive samples. Those
participants with a weakly positive result were asked to
perform a second FOBT and if, any sample was positive,
were offered colonoscopy without further testing. In
contrast, if all six samples were negative, a third FOBT
was requested; (b) spoilt kit/ technical failure: laboratory
was unable to analyze the kit. The most common reason
for a rejected kit was that the information provided with
the kit was not complete. Those participants who refused
to repeat the test after a weak positive or a spoilt kit/
technical failure were coded as an inconclusive FOBT
result; (c) negative: zero out of six positive samples;
(d) strongly positive: five or six positive samples. Those
participants with positive results were referred for a
colonoscopy. If no lesions were found in the colonoscopy
42 Short paper
0959-8278 c 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins DOI: 10.1097/CEJ.0b013e32834a7e9b
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.